2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
Facet Hypertrophy | Diagnosis & Disease Information
Sep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or falls. 1
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
Aug 9, 2022 · Undifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic autoimmune disease but do not fulfill criteria for defined connective tissue disease (eg, systemic lupus erythematosus, scleroderma, myositis, rheumatoid arthritis, Sjogren's syndrome) are classified to have UCTD.
Hydroxyapatite Crystal Deposition Disease (HADD)
Nov 15, 2022 · History and Epidemiology. A typically uniarticular condition, hydroxyapatite (HA) crystal deposition disease (HADD) is marked by the presence of hydroxyapatite crystals in the periarticular soft tissues, especially the tendons 1.HA is a mineral found in normal bone, but when it builds up in and around the joints it can cause inflammation, tenderness, and pain.
Ehlers-Danlos Syndrome - Rheumatology Advisor
Aug 10, 2022 · Ehlers-Danlos syndrome is a group of inherited connective tissue disorders that primarily affects the skin, joints, and blood vessel walls1 but can affect every organ system and result in significant morbidity and mortality. Typical clinical manifestations are skin hyperelasticity, hypermobility of joints, the fragility of blood vessels, and …
Leukocytoclastic Vasculitis - Rheumatology Advisor
Aug 4, 2022 · Diagnostic Workup. The diagnostic workup for leukocytoclastic vasculitis does not follow a uniform series of steps. If the skin biopsy indicates a diagnosis of leukocytoclastic vasculitis, the goal is to determine whether there is systemic involvement and …
Viscosupplementation for Knee Osteoarthritis - Rheumatology …
Mar 25, 2019 · Knee osteoarthritis affects at least 19% of US adults 45 years old and older. While no cure for knee osteoarthritis has been found, there are treatment options available to help people stay active and manage their pain.
Drug-Induced Lupus | Diagnosis & Disease Information
Aug 4, 2022 · Epidemiology. Drug-induced lupus occurs in people who take certain types of medication but it is not considered a drug side effect. 1, 2 Flare ups caused by medications taken for pre-existing or latent lupus are excluded from this diagnosis. 1 With drug-induced lupus, specific drugs trigger an autoimmune reaction and the production of autoantibodies. 3 There are three types of drug-induced ...
American College of Rheumatology Releases Updated Guidelines …
Jun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
Updated 2020 American College of Rheumatology Gout …
Jun 24, 2020 · The American College of Rheumatology (ACR) developed an updated set of guidelines in 2020 for the management of gout, which includes indications and use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and medication recommendations.